X4 Pharmaceuticals, Inc.
XFOR
$4.10
$0.030.74%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 107.05% | 94.11% | -27.60% | -14.80% | -24.39% |
| Total Receivables | -64.32% | -13.89% | 58.86% | -31.35% | 59.37% |
| Inventory | 9.78% | 28.71% | 2.62% | 9.66% | 15.21% |
| Prepaid Expenses | -46.31% | -5.15% | 10.55% | -19.77% | 24.82% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 347.77% | -- | -- | -- | -- |
| Total Current Assets | 96.96% | 82.07% | -23.78% | -14.69% | -21.54% |
|
|
|||||
| Total Current Assets | 96.96% | 82.07% | -23.78% | -14.69% | -21.54% |
| Net Property, Plant & Equipment | -20.17% | -31.28% | -29.93% | -14.50% | -8.51% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -1.99% | -1.94% | -1.92% | -1.87% | -1.85% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -64.84% | -16.26% | -22.00% | 44.86% | -11.98% |
| Total Assets | 77.59% | 55.52% | -19.11% | -11.22% | -17.80% |
|
|
|||||
| Total Accounts Payable | 12.73% | -34.45% | -30.64% | 28.93% | 0.51% |
| Total Accrued Expenses | 13.16% | 25.82% | 3.60% | -45.18% | 18.22% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -17.17% | -12.28% | 4.99% | 4.16% | 2.37% |
| Total Finance Division Other Current Liabilities | -43.00% | 7.96% | -11.81% | -- | -- |
| Total Other Current Liabilities | -43.00% | 7.96% | -11.81% | -- | -- |
| Total Current Liabilities | 9.58% | 2.66% | -11.54% | -21.27% | 12.37% |
|
|
|||||
| Total Current Liabilities | 9.58% | 2.66% | -11.54% | -21.27% | 12.37% |
| Long-Term Debt | 0.30% | 0.29% | 0.28% | 0.27% | 0.27% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -88.34% | -26.51% | -21.35% | -19.75% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -6.60% | 38.18% | -63.01% | -69.51% | 18.54% |
| Total Liabilities | 2.19% | 0.73% | -5.48% | -13.86% | 4.85% |
|
|
|||||
| Common Stock & APIC | 23.50% | 16.05% | 1.26% | 0.10% | 0.44% |
| Retained Earnings | -4.19% | -5.51% | -5.00% | 0.05% | -8.37% |
| Treasury Stock & Other | 7.63% | 14.49% | -7.81% | -4.92% | -7.02% |
| Total Common Equity | 202.33% | 1,451.73% | -82.69% | 3.59% | -62.85% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 202.33% | 1,451.73% | -82.69% | 3.59% | -62.85% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 202.33% | 1,451.73% | -82.69% | 3.59% | -62.85% |
|
|
|||||